ZKB CALLABLE BARRIER REVERSE CONVERTIBLE ON WORST OF - PFIZER INC/ALPHABET C/RECKITT BENCKISER Stock

Certificat

Z06YPZ

CH1214882180

Market Closed - Bid/Ask 11:20:00 2024-05-22 am EDT After market 11:15:00 am
103 EUR +0.23% Intraday chart for ZKB CALLABLE BARRIER REVERSE CONVERTIBLE ON WORST OF - PFIZER INC/ALPHABET C/RECKITT BENCKISER 102.9 -0.06%
6 months+5.71%
Current year+5.56%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change

Delayed Quote Swiss Exchange

Last update May 22, 2024 at 11:20 am EDT

More quotes

Static data

Product typeReverse Convertibles
Buy / SellCALL
Underlying PFIZER, INC.
Issuer ZKB
Z06YPZ
ISINCH1214882180
Date issued 2023-02-06
Strike 43.76 $
Maturity 2024-08-06 (70 Days)
Parity 1 : 1
Emission price 100
Emission volume N/A
Settlement both
Currency EUR

Technical Indicators

Highest since issue 103.3
Lowest since issue 94.98
Spread 7
Spread %0.68%

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.88 USD
Average target price
31.92 USD
Spread / Average Target
+10.51%
Consensus
  1. Stock Market
  2. Certificates
  3. Z06YPZ Certificat